Davallou
Davallou v. Glenmark Pharmaceuticals US Head Quarters
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 HARRY H. DAVALLOU, Case No.: 20-cv-00619-DMS-MDD
Plaintiff,
ORDER GRANTING MOTION TO
v. DISMISS GLENMARK PHARMACEUTICALS US HEAD QUARTERS, a business of 15 unknown form, 16 Defendant. 17 18 Pending before the Court is Defendant Glenmark Pharmaceuticals Inc., USA’s motion to dismiss Plaintiff Harry H. Davallou’s Complaint under Federal Rule of Civil Procedure 41(b). Plaintiff, proceeding pro se, filed a response to Defendant’s motion. For the reasons given herein, the Court grants Defendant’s motion to dismiss. I. BACKGROUND On March 3, 2020, Plaintiff filed a Complaint based on products liability in the Superior Court of California, County of San Diego. (ECF No. 1 at 11.) Plaintiff alleges that in November of 2019, his previously mild Parkinson’s disease worsened and he experienced “general weakness in [his] body.” (Id. at 14.) Plaintiff alleges that…